OCON Therapeutics secures $10M in funding led by RH Capital to revolutionize women's health with advanced drug delivery solutions
Amount Raised
$10 Million
Round Type
Funding Round
Modiin Maccabim ReutManufacturingBiotechnologyHealth CareTherapeuticsInvestors
Description
OCON Therapeutics has successfully completed a funding round of $10 million led by RH Capital. The funding will enhance OCON's ability to provide groundbreaking solutions for treating prevalent uterine pathologies, reinforcing its vision to establish a safer standard of care through its proprietary 3D drug delivery system.
Quick answer
OCON Therapeutics raised $10 Million in a Funding Round round, dated June 24, 2024. Investors: Exerte Partners, Astia Angels, Features Capital and RH Capital. OCON Therapeutics is based in Modiin Maccabim Reut, Center District, Israel.
- How much did OCON Therapeutics raise?
- OCON Therapeutics raised $10 Million in a Funding Round round on June 24, 2024.
- Who invested in OCON Therapeutics?
- Exerte Partners, Astia Angels, Features Capital and RH Capital are named as investors in this round.
- What does OCON Therapeutics do?
- OCON Therapeutics is a women-led women's health company dedicated to developing, manufacturing, and commercializing innovative drug delivery systems based on the company's patented IUB® (Intra-Uterine Ball) platform.
- Where is OCON Therapeutics based and how big is it?
- OCON Therapeutics is based in Modiin Maccabim Reut, Center District, Israel. Fundz records about 34 employees.
- Who are the decision-makers at OCON Therapeutics?
- Fundz holds 1 contact at OCON Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Manufacturing around the same time
Companies in the same sectors as OCON Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- NewcelX raised $787K on June 28, 2024.
- CASI Pharmaceuticals raised $15M (Post-IPO Equity) on June 26, 2024.
- CASI Pharmaceuticals raised $15M on June 26, 2024.
- IDRx raised $120M (Series B) on August 7, 2024.
- NeuroTherapia raised $12M (Series B) on August 6, 2024.
- PolyPid raised $14M on August 6, 2024.
Who to call at OCON Therapeutics, and when
A new round usually means OCON Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day OCON Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OCON Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OCON Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OCON Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
OCON Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.